Massive breast cancer study aims to unlock tumor secrets

NCT ID NCT01840293

Recruiting now Knowledge-focused Sponsor: Cancer Trials Ireland Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is looking at proteins and genes in breast cancer tumors from 1,780 patients. Researchers want to understand how breast cancer progresses and why it sometimes comes back. By comparing primary and recurrent tumors, they hope to find markers that could predict disease outcomes.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could lead to better understanding of breast cancer progression and identify new markers to predict recurrence.
What could go wrong: This is an observational study, so it does not test a treatment. Results may not directly improve patient care or lead to immediate clinical changes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METASTATIC BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast carcinoma breast neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PRIMARY BREAST CANCER RECURRENT/METASTATIC BREAST CANCER

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••

Locations

Beaumont Hospital
RECRUITING

Dublin, Ireland
Cork University Hospital
RECRUITING

Cork, Ireland
St James's Hospital
COMPLETED

Dublin, Ireland
St. Vincent's University Hospital
RECRUITING

Dublin, Ireland
University Hospital Limerick
ACTIVE_NOT_RECRUITING

Limerick, Ireland
University Hospital Waterford
RECRUITING

Waterford, Ireland

More trials for these conditions

Other studies related to the condition(s) this trial covers.